A recent Israeli study demonstrated that Pfizer's anti-COVID pill had no benefit for those younger than 65. However, it did show benefits among seniors at high risk for severe disease.
Built using the Forest Map Wiki
A recent Israeli study demonstrated that Pfizer's anti-COVID pill had no benefit for those younger than 65. However, it did show benefits among seniors at high risk for severe disease.
Built using the Forest Map Wiki